There is a shift in the industry towards biopharmaceuticals, but there is still great demand for synthetic APIs. We catch up with Richard Hercek, Head of API Engineering and IPC, and Boris Petrusek, EU Project Manager, at Saneca Pharma to discuss the latest trends in small-molecule API manufacture.
False
Recommended
False
Related Content

The Final Frontier?
December 1, 2014
0 min read
The Galactic Grant Competition encourages companies to use the International Space Station for pharmaceutical R&D

Calculate – Don’t Estimate – Drug Development Costs
December 1, 2014
0 min read
Researchers estimate the cost of drug development at over $1 billion, while others say it’s less than $100 million. Who’s right? And how can we accurately determine the true costs?

Electrifying R&D Acceleration
December 2, 2014
0 min read
Electrochemical reaction cells are finding new applications in the pharma R&D lab that could offer big time and cost savings...

United Science Stands
December 2, 2014
0 min read
Sitting Down With… William Chin, Executive Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA).